Gadolinium-based distinction brokers (GBCAs) are broadly used in magnetic resonance imaging (MRI) to improve the visibility of blood vessels, tumors, inflammation, along with other internal buildings. Even though typically considered Harmless, problems about GBCA toxicity have emerged over the past 20 years—especially in people with impaired kidn